Curriculum Vitae Junior Group Leader at the Institute of Biochemistry

Curriculum Vitae
Jörg Hartkamp, Ph.D.
Junior Group Leader at the Institute of Biochemistry and Molecular Biology
Medical School
RWTH Aachen University
Education
02/1997-01/2002
Ph.D. thesis: ‘Regulation of MAPK signal cascades through the
serine/threonine kinase MLK3’. Institut für Medizinische
Strahlenkunde und Zellforschung (MSZ) (Prof. Ulf R. Rapp),
Bayerische Julius Maximilians-Universität Würzburg, Germany
02/1996-01/1997
Diploma thesis: ‘Activation and regulation of the serine/threonine
kinase MLK3’. Institut für Medizinische Strahlenkunde und
Zellforschung (MSZ) (Prof. Ulf R. Rapp), Bayerische Julius
Maximilians-Universität Würzburg, Germany
11/1991-02/1996
Study of Biology, Bayerische Julius Maximilians-Universität
Würzburg, Germany
Professional experience
Since 09/2011
Junior Group leader at the Institute for Biochemistry and Molecular
Biology, RWTH Aachen University, Germany (Prof. Bernhard
Lüscher)
01/2003-08/2010
Postdoctoral Research Associate at the University of Manchester,
Department of Life Sciences, UK (Dr. Stefan Roberts)
09/2001-08/2002
Postdoctoral Research Associate at the CRC Centre for Cell and
Molecular Biology, Institute for Cancer Research, London, UK
(Dr. Richard Lamb)
Bibliography
1. Hartkamp, J. (2011). Opposing functions for the Wilms’ tumor protein 1 (WT1) in
tumorigenesis. Curr. Pediatr. Rev. 7, 316-320.
2. Hartkamp, J., and Roberts, S.G.E. (2010). HtrA2, taming the oncogenic activities
of WT1. Cell Cycle 9, 2508-2514.
3. Hartkamp, J., Carpenter, B., and Roberts, S.G.E. (2010). The Wilms’ tumour
suppressor protein WT1 is processed by the serine protease HtrA2/Omi. Mol.
Cell 37, 159-171.
4. Hartkamp, J., and Roberts, S.G.E. (2009). The role of the Wilms’ tumoursuppressor protein WT1 in apoptosis. Biochem. Soc. Trans. 36, 629-631.
5. Jaeschke, A., Hartkamp, J., Saitoh, M., Roworth, W., Nobukuni, T., Hodges, A.,
Sampson, J., Thomas, G., and Lamb, R. (2002). TSC tumor suppressor
mediated S6 kinase inhibition by PI3k is mTor independent. J. Cell Biol. 159,
217-224.
6. Offenhausser, M., Herr A., Hartkamp, J., Wauben, M., Magnus, T., Grauer, O.,
Seubert, S., Weishaupt, A., Toyka, K., Gold, R., and Troppmair, J. (2002).
Truncation of the neuritogenic peptide bP2(60-70) results in the generation of
altered peptide ligands with the potential to interfere with T cell activation. J.
Neuroimmunol. 129, 97-105.
7. Hartkamp, J., Troppmair, J., and Rapp, U.R. (1999). The JNK/SAPK activator
mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent
fashion. Cancer Res. 59, 2195-2202.
8. Troppmair, J., Hartkamp, J., and Rapp, U.R. (1998). Activation of NF-kappa B
by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the
stress kinase cascade. Oncogene 17, 685-690.

Download Report